Late cold season impacts sales
This article was originally published in The Tan Sheet
Executive Summary
Zicam manufacturer Matrixx Initiatives announces Dec. 11 it does not expect net sales and net income to reach the lower end of its previously announced guidance due to a slow start to the 2006/2007 cold season. The Phoenix-based company says the overall season-to-date incidence level is around 3% below last year and is negatively affecting its net sales growth. Matrixx Initiatives President & CEO Carl Johnson says, "Generally this trend would indicate a late cold season that should peak in the first quarter of 2007." In July, the firm announced it is developing a new oral care product offering a "very unique delivery system." It has not announced when the new product will be introduced (1"The Tan Sheet" July 31, 2006, p. 11)...
You may also be interested in...
Slow Cold Season Trims Matrixx Q4 Sales, But Net Loss Down By $2.5 Million
A slow-starting cold season contributed to an 18 percent dip in fourth-quarter sales of Matrixx Initiatives' Zicam cough/cold and flu relief products, company President and CEO Carl Johnson says
Matrixx Investment In Novel Oral Care Product Drags Down Q2 Income
Matrixx Initiatives' second-quarter profits were impacted by higher R&D expenditure on a new oral care product that offers a "very unique delivery system," the firm announced during an earnings call July 25
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.